phenprocoumon and Low-Back-Pain

phenprocoumon has been researched along with Low-Back-Pain* in 2 studies

Other Studies

2 other study(ies) available for phenprocoumon and Low-Back-Pain

Article	Year
[Clinical problems with oral anticoagulation -- 3 case reports]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1 Two patients with severe bleeding complications under oral anticoagulant treatment are presented, in one case caused by pharmacokinetic drug interference (phenylbutazone), in the other by genetic predisposition to bleeding induced by coumarin anticoagulants. Another patient with decreasing INR due to drug interference (rifampicin) is presented as well. The possibility of drug interferences with coumarin anticoagulants has to be anticipated, whenever the medication of an orally anticoagulated patient is changed. A founder mutation of the factor IX propeptide constitutes a genetic predisposition to bleeding in patients put on coumarins. Its presence should be excluded in any patient suffering from hemorrhagic complications after starting anticoagulation when INR values are in the target range. Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aortic Valve; Blood Coagulation Tests; Drug Interactions; Follow-Up Studies; Genetic Predisposition to Disease; Heart Valve Prosthesis; Hematoma; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Iatrogenic Disease; Injections, Intramuscular; Low Back Pain; Male; Middle Aged; Mitral Valve; Phenprocoumon; Phenylbutazone; Thrombophlebitis; Time Factors	2003
[An unexpected etiology of lumbo-radicular symptoms]. Praxis, 2000, Dec-07, Volume: 89, Issue:49 Topics: Aged; Diagnosis, Differential; Diagnostic Imaging; Female; Hematoma, Epidural, Cranial; Humans; Low Back Pain; Lumbar Vertebrae; Phenprocoumon; Radiculopathy	2000

Article

Year

[Clinical problems with oral anticoagulation -- 3 case reports].

Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1

Two patients with severe bleeding complications under oral anticoagulant treatment are presented, in one case caused by pharmacokinetic drug interference (phenylbutazone), in the other by genetic predisposition to bleeding induced by coumarin anticoagulants. Another patient with decreasing INR due to drug interference (rifampicin) is presented as well. The possibility of drug interferences with coumarin anticoagulants has to be anticipated, whenever the medication of an orally anticoagulated patient is changed. A founder mutation of the factor IX propeptide constitutes a genetic predisposition to bleeding in patients put on coumarins. Its presence should be excluded in any patient suffering from hemorrhagic complications after starting anticoagulation when INR values are in the target range.

Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aortic Valve; Blood Coagulation Tests; Drug Interactions; Follow-Up Studies; Genetic Predisposition to Disease; Heart Valve Prosthesis; Hematoma; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Iatrogenic Disease; Injections, Intramuscular; Low Back Pain; Male; Middle Aged; Mitral Valve; Phenprocoumon; Phenylbutazone; Thrombophlebitis; Time Factors

2003

[An unexpected etiology of lumbo-radicular symptoms].

Praxis, 2000, Dec-07, Volume: 89, Issue:49

Topics: Aged; Diagnosis, Differential; Diagnostic Imaging; Female; Hematoma, Epidural, Cranial; Humans; Low Back Pain; Lumbar Vertebrae; Phenprocoumon; Radiculopathy

2000